These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32873970)

  • 1. Soluble ligands as drug targets.
    Attwood MM; Jonsson J; Rask-Andersen M; Schiöth HB
    Nat Rev Drug Discov; 2020 Oct; 19(10):695-710. PubMed ID: 32873970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of FDA-approved drugs for inflammation and autoimmune diseases.
    Kinch MS; Merkel J
    Drug Discov Today; 2015 Aug; 20(8):920-3. PubMed ID: 25701283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TNF superfamily in 2009: new pathways, new indications, and new drugs.
    Tansey MG; Szymkowski DE
    Drug Discov Today; 2009 Dec; 14(23-24):1082-8. PubMed ID: 19837186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ligands as drug targets for treatment of inflammatory bowel disease.
    Tong X; Zheng Y; Li Y; Xiong Y; Chen D
    Pharmacol Ther; 2021 Oct; 226():107859. PubMed ID: 33895184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases.
    Clark JD; Flanagan ME; Telliez JB
    J Med Chem; 2014 Jun; 57(12):5023-38. PubMed ID: 24417533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cytokines to treat autoimmunity.
    Kyttaris VC
    Clin Immunol; 2019 Sep; 206():108251. PubMed ID: 31445171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.
    Wang X; Wong K; Ouyang W; Rutz S
    Cold Spring Harb Perspect Biol; 2019 Feb; 11(2):. PubMed ID: 29038121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecules targeting ubiquitination to control inflammatory diseases.
    Li ZQ; Chen X; Wang Y
    Drug Discov Today; 2021 Oct; 26(10):2414-2422. PubMed ID: 33992766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug targets in the cytokine universe for autoimmune disease.
    Liu X; Fang L; Guo TB; Mei H; Zhang JZ
    Trends Immunol; 2013 Mar; 34(3):120-8. PubMed ID: 23116550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.
    Hogarth PM; Pietersz GA
    Nat Rev Drug Discov; 2012 Mar; 11(4):311-31. PubMed ID: 22460124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An APRIL to remember: novel TNF ligands as therapeutic targets.
    Dillon SR; Gross JA; Ansell SM; Novak AJ
    Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern anti-cytokine therapy of autoimmune diseases.
    Astrakhantseva IV; Efimov GA; Drutskaya MS; Kruglov AA; Nedospasov SA
    Biochemistry (Mosc); 2014 Dec; 79(12):1308-21. PubMed ID: 25716724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic antibodies for autoimmunity and inflammation.
    Chan AC; Carter PJ
    Nat Rev Immunol; 2010 May; 10(5):301-16. PubMed ID: 20414204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.
    Brenke JK; Popowicz GM; Schorpp K; Rothenaigner I; Roesner M; Meininger I; Kalinski C; Ringelstetter L; R'kyek O; Jürjens G; Vincendeau M; Plettenburg O; Sattler M; Krappmann D; Hadian K
    J Biol Chem; 2018 Aug; 293(34):13191-13203. PubMed ID: 29950522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
    Jones SA; Jenkins BJ
    Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression.
    Masuda K; Kishimoto T
    Curr Pharm Des; 2018; 24(16):1766-1771. PubMed ID: 29701145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs and their molecular targets: an updated overview.
    Landry Y; Gies JP
    Fundam Clin Pharmacol; 2008 Feb; 22(1):1-18. PubMed ID: 18251718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic regulation of inflammasomes in inflammation.
    Yang Q; Liu R; Yu Q; Bi Y; Liu G
    Immunology; 2019 Jun; 157(2):95-109. PubMed ID: 30851192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.